EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Price Transparency in United States’ Health Care: A Narrative Policy Review of the Current State and Way Forward

David N Bernstein iD, Jonathan R Crowe

INQUIRY: The Journal of Health Care Organization, Provision, and Financing · 2024-01 · 61

DOI: 10.1177/00469580241255823 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift INQUIRY: The Journal of Health Care Organization, Provision, and Financing, online erschienen am 26.05.2024. Verfasst von David N Bernstein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Health Policy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Health care price transparency is gaining momentum as a tangible policy intervention that can unleash market principles to increase competition, help begin to decrease U.S. health care expenditures, and provide Americans with access to affordable, high-quality health care. Indeed, pricing reform is required to facilitate patient shopping in health care. In this narrative policy review, we offer a brief history of health care price transparency efforts and an overview of the health care price transparency literature. Further, we highlight the current rules and legislative initiatives aimed at achieving the full potential of health care price transparency. Lastly, we offer key takeaways and highlight suggestions for future policy directions, including the need to ensure hospital and insurance compliance through more appropriate penalties and incentives, importance of reducing regulation to promote financial upside that can be obtained by both patients and providers who actively promote shopping for lower cost, higher quality health care goods and services, and the need for transparent and easily found quality metrics, including outcomes most important to patients, driven by physicians “on the ground” with patient input.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PolicyUnited StatesHumansHealth ExpendituresQuality of Health CareHealth Care CostsHealth Care ReformDisclosure

Stichwörter der Autor:innen

health care economicshealth care priceshealth care transformationhealth policyprice transparency

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Business School, Soldiers Field, Boston, MA, USA.
  • Center for Health Policy and Advocacy, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

ORCID-Profile: David N Bernstein

Zitieren

APA

Bernstein, D. N., & Crowe, J. R. (2024). Price Transparency in United States’ Health Care: A Narrative Policy Review of the Current State and Way Forward. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 61. https://doi.org/10.1177/00469580241255823

Vancouver

Bernstein DN, Crowe JR. Price Transparency in United States’ Health Care: A Narrative Policy Review of the Current State and Way Forward. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2024;61. doi:10.1177/00469580241255823

BibTeX
@article{Bernstein2024,
  author = {Bernstein, David N and Crowe, Jonathan R},
  title = {Price Transparency in United States’ Health Care: A Narrative Policy Review of the Current State and Way Forward},
  journal = {INQUIRY: The Journal of Health Care Organization, Provision, and Financing},
  year = {2024},
  volume = {61},
  doi = {10.1177/00469580241255823}
}
Kostenlos starten →